a parallel, randomised, open-label clinical trial evaluating the safety and efficacy of methotrexate with apremilast in patients with moderate to severe palmoplantar psoriasis. Int. J. Pharm. Sci. Lett. [Internet]. 2020 Jan. 3 [cited 2026 Oct. 13];10(1):29-3. Available from: https://ijpsl.org/index.php/ijpls/article/view/7